| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30049777 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049778 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049779 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049780 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049781 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049782 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049783 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049784 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049785 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
| TVIS30049786 | HIV | ENSG00000084676.16 | protein_coding | NCOA1 | No | No | 8648 | Q15788 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | NCOA1 |
|---|---|
| DrugBank ID | DB04652 |
| Drug Name | Corticosterone |
| Target ID | BE0003728 |
| UniProt ID | Q15788 |
| Regulation Type | |
| PubMed IDs | 10592235 |
| Citations | Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Experimental |
| Direct Classification | 21-hydroxysteroids |
| SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO |
| Pathways | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency; Apparent Mineralocorticoid Excess Syndrome; Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH; 3-beta-Hydroxysteroid Dehydrogenase Deficiency; Corticosterone Methyl Oxidase I Deficiency (CMO I); 11-beta-Hydroxylase Deficiency (CYP11B1); Steroidogenesis; Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency; 17-alpha-Hydroxylase Deficiency (CYP17); Corticosterone Methyl Oxidase II Deficiency (CMO II); 21-Hydroxylase Deficiency (CYP21) |
| PharmGKB | |
| ChEMBL | CHEMBL110739 |
